Article
Engineering Adhesion of the Probiotic Strain Escherichia coli Nissle to the Fungal Pathogen Candida albicans
12 Sept 2024
Abstract excerpt
High Resolution Image Download MS PowerPoint Slide Engineering live biotherapeutic products against fungal pathogens such as Candida albicans has been suggested as a means to tackle the increasing threat of fungal infections and the development of resistance to classical antifungal treatments. One important challenge in the design of live therapeutics is to control their localization inside the human body. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
